24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825
Fax: (361)578-5500

Medical Disorders
Resources
Basic InformationLookupsLatest News
AHA News: How Bacteria in Your Gut Interact With the Mind and BodyMusic Might Help Soothe Ailing HeartsCould an Injected Electrode Control Your Pain Without Drugs?100,000 Dead, 40 Million Unemployed: America Hits Grim Pandemic MilestonesFDA Approves IV Artesunate for Severe Malaria'Silent' COVID-19 More Widespread Than ThoughtDrug Combos May Be Advance Against Heart FailurePollen Fragments Linger After Rains, Leaving Allergy Sufferers MiserableA New Hip or Knee Can Do a Marriage Good, Study FindsOnly Half of Americans Say They'd Get a Coronavirus Vaccine: SurveyAlzheimer's Gene Linked to Severe COVID-19 RiskCoronavirus Cases Ticking Upwards in Nearly a Dozen U.S. StatesLockdown Got You Down? Experts Offer Tips to De-StressCould a Hormone Help Spur High Blood Pressure?Nursing Homes Are Ground Zero for COVID-19Getting Back to Work Safely After LockdownRemdesivir Will Not Be Enough to Curb COVID-19, Study FindsOutdoor Swimming Pools Not a COVID-19 Risk: ExpertStrokes Are Deadlier When They Hit COVID-19 PatientsAHA News: How to Accurately Measure Blood Pressure at HomeU.S. Earmarks $1.2 Billion for New Vaccine Deal as Coronavirus Deaths Near 95,000During the Pandemic, How Safe Is the Great American Summer Vacation?COVID-19 Damages Lungs Differently From the Flu: StudyMore Evidence Hydroxychloroquine Won't Help, May Harm COVID-19 PatientsYour Sleep Habits May Worsen Your AsthmaExtra Pounds Could Bring More Painful JointsCOVID Can Complicate Pregnancy, Especially If Mom Is ObeseWHO Predicts COVID-19 Will Take Heavy Toll in AfricaCombining Remdesivir With Other Meds Could Boost COVID-Fighting PowerMultiple Sclerosis Ups Odds for Heart Trouble, StrokeAHA News: Not Wanting to Burden Busy Hospitals, She Disregarded Heart Attack SignsExperimental Vaccines Shield Monkeys From CoronavirusHeart Attack Cases at ERs Fall by Half – Are COVID Fears to Blame?Asthma Ups Ventilator Needs of Younger Adults With COVID-19: Study1 in 5 Hospitalized NYC COVID-19 Patients Needed ICU CareObesity Ups Odds for Dangerous Lung Clots in COVID-19 PatientsDoes 6 Feet Provide Enough COVID Protection?COVID-19 Antibodies May Tame Inflammatory Condition in Kids: StudyAs Americans Return to Work, How Will COVID Change the Workplace?COVID and Hypochondria: Online Therapy May Help Ease FearsAHA News: Is High Blood Pressure Inevitable?People Mount Strong Immune Responses to Coronavirus, Boding Well for a VaccineProms Gone, Graduations Online: Pandemic Cancels Kids' Rites of PassageDon't Delay If Cancer Symptoms Appear – Call Your DoctorPulmonary Rehab Can Help People With COPD, So Why Do So Few Get It?COVID-19 Will Delay 28 Million Elective Surgeries Worldwide: StudyMost U.S. States Reopening as Coronavirus Cases DeclineRate of New U.S. Coronavirus Cases Is DecliningCould Certain Chemicals Trigger Celiac Disease?Poor Americans Likely to Miss Preventive Heart Screenings: Study
Questions and AnswersLinks
Related Topics

Diabetes

Bladder Drug Can Cause Eye Damage: Study

HealthDay News
by -- Robert Preidt
Updated: Oct 15th 2019

new article illustration

TUESDAY, Oct. 15, 2019 (HealthDay News) -- The widely used bladder drug Elmiron may cause eye damage, a new study claims.

A report released last year suggested that the drug -- known as pentosan polysulfate sodium and used by hundreds of thousands of people for decades -- may be toxic to the retina, the light-sensing tissue at the back of the eye.

That led researchers to examine a database of 4.3 million patients at Kaiser Permanente in Northern California.

The three Kaiser Permanente ophthalmologists who conducted the study identified 140 patients who'd taken an average of 5,000 pills each over 15 years. Of those 140 patients, 91 agreed to an exam, and the researchers took detailed images of the back of their eyes.

Twenty-two of the 91 patients showed clear signs of Elmiron toxicity. The rate of toxicity rose with the amount of Elmiron taken, from 11% of those taking 500 to 1,000 grams to 42% of those taking 1,500 grams or more.

The findings showed that about one-quarter of patients who'd taken large amounts of Elmiron had clear signs of eye damage, and that damage caused by the drug could be mistaken for other retinal conditions, such as age-related macular degeneration or pattern dystrophy.

Elmiron is the only drug approved in the United States to treat interstitial cystitis, which causes chronic pain in the bladder and pelvis area. It's estimated that more than 1 million people in the United States, mostly women, have the condition.

"It's unfortunate. You have a patient with a chronic condition like interstitial cystitis, for which there is no cure and no effective treatment. They get put on these medications because it's thought to have few side effects and few risks, and no one thinks about it again. And year after year, the number of pills they're taking goes up and up," study author Dr. Robin Vora said in an American Academy of Ophthalmology (AAO) news release.

It's unclear how much Elmiron is too much, so patients who show no signs of toxicity should be screened for retinal damage at least once a year, Vora said.

Those who do have signs of eye damage should speak with their urologist or ob/gyn about discontinuing the medication, he advised.

If it's identified early, the eye damage caused by Elmiron may be limited by stopping the medication, according to the researchers.

The research was to be presented Oct. 12 at the annual meeting of the AAO, in San Francisco. Findings presented at scientific meetings should be considered preliminary until published in a peer-reviewed journal.

More information

The U.S. National Eye Institute offers advice on eye health.